Liver Transplant: Cirrhosis, MELD Score, and Waiting List Process

Liver transplant may be considered when cirrhosis or another advanced liver disease can no longer be controlled with medical treatment. Understanding the MELD score, transplant evaluation, and waiting list process can help patients and families prepare with clearer expectations.

Overview

A liver transplant is an operation that replaces a severely damaged liver with a healthy liver from a donor. The donor liver may come from a deceased donor, or in selected cases, a portion of liver may come from a living donor. Because the liver can regenerate, a partial liver graft can grow and function well in the recipient, while the donor’s remaining liver also regrows over time.

Transplant is considered when liver disease has reached an advanced stage and standard treatments can no longer keep the person stable or maintain an acceptable quality of life. This stage is often called end-stage liver disease. It does not always mean that death is immediate, but it does mean the liver has lost much of its ability to perform essential functions such as filtering toxins, producing proteins, regulating clotting, processing nutrients, and supporting immunity.

Cirrhosis is a leading reason for liver transplant. In cirrhosis, long-term injury causes scar tissue to replace healthy liver tissue. Over time, scarring can block normal blood flow through the liver and reduce liver function. A transplant team carefully weighs the risks and benefits for each person, because transplantation is major surgery followed by lifelong medical care.

Cirrhosis and When Transplant Is Considered

Cirrhosis may remain compensated for years, meaning the liver is scarred but still able to perform many important tasks. In this stage, treatment focuses on controlling the cause, monitoring for liver cancer, preventing complications, and supporting overall health. Transplant usually becomes a discussion when cirrhosis becomes decompensated, meaning complications appear or liver function worsens.

Common signs of decompensated cirrhosis include fluid buildup in the abdomen, called ascites; confusion or sleepiness from hepatic encephalopathy; bleeding from enlarged veins in the esophagus or stomach, called varices; jaundice; kidney problems; and repeated infections. Some people may also be evaluated for transplant because of liver cancer that meets transplant criteria, even if their liver function is relatively preserved.

Not every person with cirrhosis needs a transplant, and not every person is a candidate. Some conditions may make transplant unsafe until they are treated or stabilized, such as uncontrolled infection, active substance use disorder without recovery support, severe heart or lung disease, or cancer outside accepted transplant criteria. The evaluation process is designed to identify risks, treat modifiable problems, and determine whether transplantation is likely to provide meaningful benefit.

Understanding the MELD Score

The MELD score, short for Model for End-Stage Liver Disease, is a calculation used to estimate the medical urgency of chronic liver disease. In many transplant systems, it helps determine priority on the waiting list for deceased donor liver transplantation. A higher MELD score generally reflects more severe liver dysfunction and a greater short-term risk of death without transplant.

The MELD score is based on routine blood test results that reflect liver and kidney function and blood clotting. Depending on the system used, the calculation may include bilirubin, INR, creatinine, sodium, and whether the person is receiving dialysis. These values can change over time, so the score is repeated at intervals determined by the patient’s condition and local transplant policy.

The MELD score is important, but it is not the only factor in transplant planning. Blood type, body size, donor organ availability, geographic allocation rules, urgency exceptions, and special conditions such as certain liver cancers can also influence timing. Some patients may feel very unwell even with a moderate MELD score, while others with a high score may appear relatively stable. This is why transplant decisions rely on full clinical assessment, not a number alone.

Transplant Evaluation and Waiting List Process

Before joining a liver transplant waiting list, a patient goes through a detailed evaluation. The purpose is to confirm the diagnosis, measure disease severity, identify other medical risks, and make sure the patient can safely undergo surgery and the demanding care that follows. The process also allows patients and families to ask questions and understand practical expectations.

Evaluation commonly includes blood tests, liver imaging, heart and lung assessment, kidney function review, infection screening, cancer screening, nutrition assessment, and review of vaccinations. Patients may also meet hepatologists, transplant surgeons, anesthesiologists, nurses, dietitians, pharmacists, social workers, psychologists, and financial or international patient coordinators when relevant.

Psychosocial assessment is an essential part of transplant care. The team considers whether the patient has reliable support, can attend frequent appointments, can take medications as prescribed, and has addressed alcohol, drug, or tobacco-related risks where applicable. This is not meant to judge the patient; it helps create the safest plan for long-term success.

After the evaluation, a transplant committee reviews the case. If the patient is accepted, they may be placed on the waiting list. While waiting, the person remains under close medical monitoring, and the MELD score may be updated. If health changes significantly, the transplant team should be informed promptly because the timing, priority, or suitability for transplant may need to be reassessed.

Treatment Options: Deceased Donor and Living Donor Transplant

In a deceased donor liver transplant, the liver comes from a donor who has died and whose organs are suitable for transplantation. Allocation is guided by medical urgency, compatibility, and local or national rules. When an organ becomes available, the patient may need to come to the hospital quickly for final testing and surgery preparation.

Living donor liver transplant is another option in selected patients. A healthy adult donor gives a portion of the liver, usually after extensive medical, surgical, and psychological evaluation. Living donation can reduce waiting time for some patients, but donor safety is always a central priority. The donor must be fully informed, medically suitable, and able to decide freely without pressure.

The transplant operation is complex and usually involves removing the diseased liver, implanting the donor liver, and connecting blood vessels and bile ducts. After surgery, patients are monitored in intensive care or a specialized transplant unit. Recovery time varies depending on the person’s pre-transplant health, complications, and response to the new liver.

After transplant, immunosuppressive medicines are required to reduce the risk of rejection. These medications must be taken exactly as prescribed. Follow-up care includes blood tests, medication adjustments, infection prevention, monitoring for rejection, and management of conditions such as diabetes, high blood pressure, kidney strain, or bone health changes that may occur after transplantation.

Living With Cirrhosis While Waiting

Waiting for a liver transplant can be emotionally and physically challenging. The goal during this period is to remain as stable and strong as possible. Patients should keep all appointments, complete recommended tests on time, and contact the transplant team before starting new medicines, supplements, or herbal products, as some can harm the liver or interact with prescribed treatments.

Nutrition is especially important in cirrhosis. Many patients lose muscle even if they retain fluid and appear heavier. A doctor or dietitian may recommend adequate protein, balanced meals, safe sodium restriction for fluid control, and small frequent meals if appetite is poor. Alcohol should be avoided completely in patients with liver disease unless a doctor has given specific guidance, and smoking cessation is encouraged.

Self-care during the waiting period may include:

• Taking medicines exactly as prescribed, including diuretics, lactulose, rifaximin, beta blockers, or other treatments when ordered by a physician.
• Monitoring for fluid buildup, confusion, fever, black stools, vomiting blood, worsening jaundice, or reduced urination.
• Staying up to date with recommended vaccines and infection prevention advice.
• Maintaining safe physical activity, such as walking or supervised exercise, as tolerated.
• Keeping a support person informed and available for urgent calls from the transplant center.

Patients should also plan practical matters in advance, such as transportation, hospital bag preparation, caregiver availability, medication lists, and documents requested by the transplant center. These steps can reduce stress if an organ offer is received.

Possible Risks and Long-Term Follow-Up

Liver transplant can be life-saving, but like all major surgery, it carries risks. Early risks may include bleeding, infection, blood clots, bile duct problems, poor function of the new liver, kidney problems, or the need for additional procedures. The transplant team monitors closely for these issues and treats them promptly when they occur.

Rejection can happen when the immune system recognizes the new liver as foreign. Many rejection episodes can be treated effectively if detected early, which is why regular blood tests and follow-up visits are essential. Patients should never stop or change immunosuppressive medicines without medical advice, even if they feel well.

Long-term care focuses on protecting the transplanted liver and overall health. This includes monitoring medication side effects, preventing infections, screening for certain cancers, managing weight and metabolic health, and avoiding alcohol or liver-toxic substances. If the original liver disease can recur, such as viral hepatitis, autoimmune liver disease, or fatty liver disease, ongoing management remains important.

When to See a Doctor

People with cirrhosis should have regular follow-up with a liver specialist, even when symptoms are mild. A transplant referral is often appropriate when complications such as ascites, variceal bleeding, hepatic encephalopathy, jaundice, kidney dysfunction, or liver cancer develop. Early referral does not mean transplant will happen immediately; it allows time for evaluation and planning before a crisis occurs.

Urgent medical attention is needed for vomiting blood, black or tar-like stools, severe confusion, high fever, severe abdominal pain, rapid worsening of swelling, fainting, or markedly reduced urination. These symptoms may indicate complications that require prompt treatment. Patients on a transplant waiting list should also inform their transplant team about hospitalizations, infections, new diagnoses, or major medication changes.

For international patients, coordination between the home physician and transplant center is important. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat liver disease and transplant candidates, including international patients, with individualized medical assessment and follow-up planning. Decisions about transplant eligibility and timing should always be made by qualified transplant professionals after a complete evaluation.

Frequently asked questions

What is a liver transplant?

A liver transplant is surgery to replace a severely diseased liver with a healthy donor liver or part of a liver. It is usually considered when advanced liver disease can no longer be controlled with standard medical treatment. After transplant, patients need lifelong follow-up and medicines to reduce rejection risk.

Does everyone with cirrhosis need a liver transplant?

No. Many people with cirrhosis can be managed for years with medications, lifestyle changes, monitoring, and treatment of the underlying cause. Transplant is usually considered when cirrhosis becomes decompensated or when certain liver cancers meet transplant criteria.

What does the MELD score mean?

The MELD score is a calculation based on blood tests that estimates the severity and short-term urgency of liver disease. A higher score generally means the patient is more medically urgent for transplant. However, transplant priority also depends on factors such as blood type, donor availability, body size, allocation rules, and special exception criteria.

How long is the liver transplant waiting list?

Waiting time varies widely and cannot be predicted exactly for every patient. It depends on the patient’s MELD score, blood type, body size, local organ availability, and transplant allocation rules. Some patients may also be evaluated for living donor transplant if appropriate.

Can a living person donate part of their liver?

Yes, living donor liver transplant is possible in selected cases because the liver can regenerate. The potential donor must undergo a detailed evaluation to confirm that donation is medically and psychologically safe. Donor safety and voluntary informed consent are essential.

What happens after a liver transplant?

After surgery, patients are monitored closely in the hospital and then continue frequent outpatient follow-up. They must take immunosuppressive medicines as prescribed to reduce rejection risk. Long-term care includes blood tests, infection prevention, medication management, and monitoring for recurrence of liver disease or other health problems.

References

• World Health Organization
• European Association for the Study of the Liver
• American Association for the Study of Liver Diseases
• United Network for Organ Sharing
• National Institute of Diabetes and Digestive and Kidney Diseases

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.